Latest filing published 16 Sept 2019 for Avenue Therapeutics, INC., €91k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +89.9%Entry US$6,783.75 · Close at T+365 US$12,881.25
- +11.9%Entry US$1.34 · Close at T+365 US$1.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Elizabeth Garrett Ingram: trading record in brief
This profile gathers the share dealings of Elizabeth Garrett Ingram across 2 companies, led by Mannkind Corp and Avenue Therapeutics, Inc. We count 4 filings; the first trade dates from 14 June 2018 and the latest from 12 September 2019.
No open-market sale appears; the market trades are 2 purchases worth €95k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 share grants. 2019 to date brings 2 purchases and no sales.
Most recently, on 16 September 2019, the filings show an open-market purchase worth €91k in Avenue Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Elizabeth Garrett Ingram
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 16,000 shares@ US$6.27100.0% of flowCommon StockSEC:0001144204-19-044714:0Canonical exit: 11 Dec 2019 (T+90)
- 11,871 shares0Restricted Stock UnitSEC:0001209191-19-012813:0
- 5,000 shares@ US$1.079.7% of flowCommon Stock, $.01 Par ValueSEC:0001209191-19-006270:0Canonical exit: 1 May 2019 (T+90)
- 26,041 shares@ US$1.9290.3% of flowCommon Stock, $0.01 Par ValueSEC:0001209191-18-037771:0
4 of 4 declarations